Inflammatory diseases of the aorta include routine atherosclerosis, aortitis, periaortitis, and
atherosclerosis with excessive inflammatory responses, such as inflammatory …

In past years, there has been considerable pessimism over the role of chemotherapy in non-
small cell lung cancers. The pessimism was largely derived from the fact that alkylating …

BACKGROUND The National Institutes of Health (NIH) Revitalization Act of 1993 mandated
the appropriate inclusion of minorities in all NIH‐funded research. Twenty years after this …

ContextMore persons in the United States die from non–small cell lung cancer (NSCLC)
than from breast, colorectal, and prostate cancer combined. In preclinical testing, oral …

PURPOSE: This randomized trial was designed to determine whether paclitaxel plus
carboplatin (PC) offered a survival advantage over vinorelbine plus cisplatin (VC) for …

OBJECTIVE—To quantitate plasma ceramide subspecies concentrations in obese subjects
with type 2 diabetes and relate these plasma levels to the severity of insulin resistance …

PURPOSE Cisplatin has played a major role in the treatment of non-small-cell lung cancer
(NSCLC). This randomized trial was performed by the Southwest Oncology Group (SWOG) …

Purpose Early clinical studies with gefitinib showed promising efficacy and mild toxicity in
patients with advanced non–small-cell lung cancer (NSCLC). Thus, gefitinib was an ideal …

Purpose We assessed the safety and antitumor activity of avelumab, a fully human anti–
programmed death-ligand 1 (PD-L1) IgG1 antibody, in patients with refractory metastatic …

The recent successes of immunotherapy have shifted the paradigm in cancer treatment, but
because only a percentage of patients are responsive to immunotherapy, it is imperative to …